What are the drugs and doses for VTE prophylaxis in clinical and surgical inpatients?
VTE prophylaxis in clinical and surgical inpatients involves using LMWH, DOACs, UFH, and fondaparinux, with doses tailored to surgical context, patient renal function, and other factors. No direct comparative evidence suggests universally superior choices, emphasizing individualized regimen decisions.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.5281/zenodo.24310615
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00